BU-NOT-SET

CONTACT US
Challenges and solutions to enhancing mRNA stability with lyophilisation processes
  • Drug product
  • Industry trends
Lyo
Insight
A well-equipped CDMO for OSD contract manufacturing
  • Industry trends
  • Manufacturing
OSD contract manufacturing
Insight
Optimising efficiency with technological innovation in analytical testing
  • Analytical chemistry
  • Industry trends
Optimising efficiency
Insight
Progress your biologic with Advanced Bio comprehensive services
  • Biologics
Recipharm Advanced Bio labs
Brochure
Innovation & leadership across the advanced therapy space
  • Biologics
Innovation
Insight
Overcoming oncolytic virus obstacles with the help of a CDMO partnership
  • Biologics
oncolytic virus
Insight
Webinar: Beyond borders: Navigating global scale-up for viral-based therapies
  • Biologics
webinar
Webinar
Choosing the right container for your sterile drug product
  • Drug product
Vials
eBook
Cell and virus banking in OV development and manufacturing
  • Biologics
Cell and virus banking
White paper
Insight
  • Analytical chemistry
The QbD approach: Key advantages in clinical and commercial phases
Report
  • Sustainability
Sustainability report 2020
Poster
  • Drug substance
Recipharm and Oncopeptides: Successful collaboration in the development of melflufen, a peptidase-potentiated alkylating agent in clinical trials
Fact sheet
  • Analytical chemistry
Recipharm Analytical Solutions™
Fact sheet
  • Analytical chemistry
Impurity identification
Fact sheet
  • Analytical chemistry
Stability studies
Fact sheet
  • Analytical chemistry
Extractables & leachables testing
Insight
  • Industry trends
Pharmaceutical mergers and acquisitions: opportunities and drivers for CDMOs
Insight
  • Industry trends
Global expansion in the CDMO field